1 Global Placenta Market Outlook
In 2024, the global placenta market reported a total consumption of 3,427 thousand units. This figure encapsulates the collective demand for placenta across various applications, including pharmaceuticals, cosmetics, and supplements. The market, characterized by its use in enhancing human health and beauty, is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 8.64% from 2024 to 2029, signaling a robust expansion in the market size over the coming years.
Placenta, often dubbed the “fountain of life,” for its regenerative properties, is increasingly sought after for its potential to improve health and delay aging. This growing recognition, coupled with a rising demand for natural and holistic health solutions, is a key factor in the market’s consumption trends.
Figure Global Placenta Market Consumption and CAGR in 2024
2 Placenta Market Growth Drivers and Constraints
The placenta market is driven by several factors. The pharmaceutical sector leads the charge, with placenta’s historical use in traditional medicine and its modern applications in regenerative therapies. The market also benefits from a growing interest in cosmetic applications, as placenta’s rejuvenating properties are leveraged for anti-aging benefits. Moreover, supplement products infused with placenta are gaining popularity for their perceived health improvements.
However, the market faces limitations. One of the primary challenges is the relatively high cost of raw materials and labor, attributed to the intricate extraction and processing methods required to ensure efficacy and safety. Additionally, regulatory hurdles across different regions pose significant barriers, necessitating careful navigation by market players. These factors, among others, could potentially restrict the market’s growth.
3 Placenta Market Technological Innovations and Corporate Strategies Analysis
In terms of technological advancements, the market is witnessing innovations in extraction and processing techniques that aim to preserve the potency and safety of placenta derivatives. Companies are focusing on methods that ensure the integrity of the placenta’s cellular structure, leading to products with enhanced efficacy and stability.
Corporate strategies in the placenta market often involve mergers and acquisitions to consolidate market positions and expand product portfolios. These strategies not only enhance market presence but also foster innovation through the amalgamation of different technological expertise and distribution networks. For instance, the merger between Cargotec and Konecranes is set to create a global leader in sustainable material flow solutions, potentially benefiting the placenta market with enhanced capabilities.
4 Global Placenta Market Analysis by Application
The global placenta market, as of 2024, exhibits a diverse landscape with distinct applications driving its consumption. Each application leverages the unique properties of placenta to cater to specific needs in the pharmaceutical, cosmetic, and supplement industries.
Pharmaceuticals lead the pack in placenta consumption, accounting for a significant portion of the market. In 2024, this sector consumed approximately 1,701.6 thousand units of placenta. The primary use in pharmaceuticals revolves around placenta’s therapeutic properties, including its potential to stimulate cell regeneration and its historical use in traditional medicines. The pharmaceutical industry’s demand for placenta is further amplified by ongoing research into its regenerative capabilities, which are believed to hold promise for treating a variety of conditions, from skin diseases to more complex health issues.
Cosmetics is another pivotal sector within the placenta market. In 2024, this sector consumed approximately 536.5 thousand units of placenta. Placenta’s role in cosmetics is primarily due to its perceived anti-aging benefits and its use in promoting skin health and beauty. The inclusion of placenta in cosmetic products is driven by consumer demand for natural and effective beauty solutions, making it a popular choice in the industry.
Supplements, which incorporate placenta for its health benefits, also constitute a notable segment of the market. In 2024, this sector consumed approximately 1,187.6 thousand units of placenta. Placenta supplements are sought after for their potential to enhance overall well-being, improve energy levels, and support postpartum recovery. The supplement industry’s use of placenta reflects a broader consumer shift towards health-conscious choices and natural ingredients.
Table Global Placenta Consumption and Market Share by Application in 2024
Application |
Consumption (K Units) |
Market Share (%) |
---|---|---|
Pharmaceutical |
1,701.6 |
49.67 |
Cosmetics |
536.5 |
15.68 |
Supplements |
1,187.6 |
34.65 |
5 Global Placenta Market Analysis by Region
In 2024, the United States stands out as the largest consumer of placenta, with a consumption volume reaching 938.6 thousand units. This leading position can be attributed to the country’s robust healthcare sector and a growing trend towards alternative and regenerative medicines. The US market’s value is further solidified by a strong inclination towards cosmetic and supplement products that incorporate placenta, reflecting a consumer preference for natural and potentially beneficial ingredients.
China’s placenta consumption in 2024 is significant, totaling 347.8 thousand units. The Chinese market is characterized by a diverse range of applications, from traditional medicine to modern cosmetics. The country’s vast population and increasing disposable income levels are key drivers for this demand. Moreover, China’s investment in R&D for innovative placenta-based products is expected to further boost its market presence.
Japan, with a consumption of 435.1 thousand units in 2024, showcases a steady demand for placenta, particularly in the cosmetic and pharmaceutical sectors. The Japanese market is known for its preference for high-quality products, driving the demand for placenta in skincare and therapeutic applications.
Figure Global Placenta Market Consumption (K Units) by Region in 2024
6 Analysis of the Top 5 Companies in the Placenta Market
6.1 MiMedx Group, Inc.
Company Introduction and Business Overview
MiMedx Group, Inc., established in 1985, is a leading medical device company headquartered in the United States. The company primarily focuses on developing and commercializing placenta-based biomaterials for soft tissue repair and other medical applications. MiMedx Group has a strong presence in the global market, with its products being used in various healthcare settings to promote healing and tissue regeneration.
Products Offered
MiMedx Group offers a range of placenta-based products, with EpiFix being one of its flagship products. EpiFix is a tissue matrix allograft composed of dehydrated human amnion/chorion membrane (dHACM) that preserves multiple extracellular matrix proteins, growth factors, cytokines, and other specialty proteins. The product is processed through the proprietary PURION® process, which protects the delicate scaffold during processing, resulting in a durable allograft with natural barrier properties.
6.2 Japan Bio Products Co. Ltd.
Company Introduction and Business Overview
Japan Bio Products Co. Ltd., founded in 1954 and based in Tokyo, Japan, is a renowned manufacturer of placental extracts and related products. The company has a strong focus on extracting a variety of growth factors, cytokines, and other physiologically active substances from human placenta using unique technologies. Japan Bio Products Co. Ltd. ensures the safety and efficacy of its products through rigorous safety measures and adherence to existing scientific standards.
Products Offered
One of the key products offered by Japan Bio Products Co. Ltd. is Laennec, an ethical drug that supports liver functions in chronic liver diseases. Laennec contains hepatocyte growth factors and other substances that help speed up the regeneration of a damaged liver and aid in its recovery. The product is available in different forms, including injections, to cater to the needs of patients and healthcare providers.
6.3 Japan Natural Laboratories Co. Ltd
Company Introduction and Business Overview
Established in 1989, Japan Natural Laboratories Co. Ltd. is a prominent cosmetics manufacturer and seller based in the Asia-Pacific region. The company specializes in the production of placenta-based cosmetics and health food products, offering a wide range of options to consumers seeking the benefits of placenta extracts. Japan Natural Laboratories Co. Ltd. is committed to delivering high-quality products that enhance beauty and promote overall well-being.
Products Offered
Japan Natural Laboratories Co. Ltd. offers an extensive range of placenta-based cosmetics, including beauty essence, lotion, cream, emulsion, sunscreen, eye cream, mask, and cleansing products. These products are designed to harness the regenerative and nourishing properties of placenta extracts, providing users with improved skin health, hydration, and radiance.
6.4 Placenta Plus
Company Introduction and Business Overview
Placenta Plus, based in the United Kingdom, is a leading placenta encapsulation company that has worked with over 10,000 families since its inception. The company is dedicated to providing high-quality placenta encapsulation services, ensuring that new mothers can benefit from the nutrients and potential health advantages of their own placenta in a convenient and safe manner. Placenta Plus continually strives to develop and improve its products and services to maintain its position as a top provider in the market.
Products Offered
Placenta Plus offers a variety of placenta-based products, including Simple Method Placenta Pills, Steamed Method Placenta Pills, and Gummies with Tincture. These products are designed to provide new mothers with a convenient way to consume their own placenta, which is believed to offer benefits such as increased energy levels, improved mood, and reduced postpartum depression.
6.5 Atlanta Placenta
Company Introduction and Business Overview
Atlanta Placenta, based in the United States, is a company that offers a wide variety of services to support new mothers, including placenta encapsulation. The company is dedicated to providing high-quality placenta preparation services, ensuring that new mothers can benefit from the nutrients and potential health advantages of their own placenta in a safe and convenient manner. Atlanta Placenta is committed to delivering exceptional customer service and satisfaction, helping new mothers navigate the postpartum period with ease and confidence.
Products Offered
Atlanta Placenta offers a range of placenta-based products and services, including the Basic Package, which consists of an encapsulated placenta (TCM or Raw preparation, with or without a standard blend of herbs), a raw tincture, a placenta print, and a cord keepsake. This comprehensive package provides new mothers with a holistic approach to postpartum care, allowing them to preserve the memories of their childbirth experience while also benefiting from the potential health advantages of placenta consumption.
PART 01: EXECUTIVE SUMMARY
1.1 World Market Overview
1.1.1 Global Placenta Consumption 2019-2029
1.1.2 Placenta Consumption CAGR by Region
1.2 Placenta Segment by Application
1.2.1 Pharmaceutical
1.2.2 Cosmetics
1.2.3 Supplements
1.3 Placenta Consumption by Application
1.3.1 Global Placenta Consumption Market Share by Application (2019-2024)
1.3.2 Global Placenta Value and Market Share by Application (2019-2029)
1.3.3 Global Placenta Sale Price by Application (2019-2024)
1.4 Key Findings
PART 02: SCOPE OF THE REPORT
2.1 Market Introduction
2.2 Research Objectives
2.3 Years Considered
2.4 Market Research Methodology
2.5 Industry-related Technology and Application Field Introduction
2.5.1 Industry Technical Analysis
2.6 Interviewing Overview
2.7 Currency Considered
PART 03: RESEARCH METHODOLOGY
3.1 Methodology
3.2 Research Data Source
3.2.1 Secondary Data
3.2.2 Primary Data
3.2.3 Market Size Estimation
3.2.4 Legal Disclaimer
PART 04: MARKET LANDSCAPE
4.1 Market Ecosystem
4.2 Market Characteristics
4.3 Market Segmentation Analysis
PART 05: MARKET SIZING
5.1 Market Definition
5.1.1 Effects and Side Effects of Placenta
5.1.2 Placentas Manufacturing Process Analysis
5.2 Market Sizing 2019
5.3 Market Size and Forecast 2019-2024
PART 06: FIVE FORCES ANALYSIS
6.1 Bargaining power of buyers
6.2 Bargaining power of suppliers
6.3 Threat of new entrants
6.4 Threat of substitutes
6.5 Threat of rivalry
PART 07: MARKET SEGMENTATION BY APPLICATION
7.1 Downstream Market Overview
7.2 Global Placenta Consumption and Market Share by Application (2019-2024)
7.3 Global Placenta Consumption and Growth Rate by Application (2019-2024)
7.3.1 Global Placenta Consumption and Growth Rate of Pharmaceutical (2019-2024)
7.3.2 Global Placenta Consumption and Growth Rate of Cosmetics (2019-2024)
7.3.3 Global Placenta Consumption and Growth Rate of Supplements (2019-2024)
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
9.1 Americas Placenta Market Size and Forecast
9.2 APAC Placenta Market Size and Forecast
9.3 EMEA Placenta Market Size and Forecast
9.4 Key Leading Countries
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
11.1 Market Drivers
11.2 Market Challenges
11.3 MARKET TRENDS/ Opportunity
PART 12: VENDOR LANDSCAPE
12.1 Overview
12.2 Landscape Disruption
12.3 Competitive scenario
12.4 Key Market Vendors
PART 13: VENDOR ANALYSIS
13.1 MiMedx Group, Inc.
13.1.1 MiMedx Group, Inc. Company Details
13.1.2 Company Product Offered
13.1.3 MiMedx Group, Inc. Placenta Sales, Revenue and Gross Margin (2019-2024)
13.1.4 MiMedx Group, Inc. Placenta Business Overview
13.1.5 MiMedx Group, Inc. News
13.2 Japan Bio Products Co. Ltd.
13.2.1 Japan Bio Products Co. Ltd. Company Details
13.2.2 Company Product Offered
13.2.3 Japan Bio Products Co. Ltd. Placenta Sales, Revenue and Gross Margin (2019-2024)
13.2.4 Japan Bio Products Co. Ltd. Business Overview
13.3 Japan Natural Laboratories Co. Ltd
13.3.1 Japan Natural Laboratories Co. Ltd Company Details
13.3.2 Company Product Offered
13.3.3 Japan Natural Laboratories Co. Ltd Placenta Sales, Revenue and Gross Margin (2019-2024)
13.3.4 Japan Natural Laboratories Co. Ltd Placenta Business Overview
13.4 Placenta Plus
13.4.1 Placenta Plus Company Details
13.4.2 Company Product Offered
13.4.3 Placenta Plus Placenta Sales, Revenue and Gross Margin (2019-2024)
13.4.4 Placenta Plus Placenta Business Overview
13.5 Atlanta Placenta
13.5.1 Atlanta Placenta Company Details
13.5.2 Company Product Offered
13.5.3 Atlanta Placenta Placenta Sales, Revenue and Gross Margin (2019-2024)
13.5.4 Atlanta Placenta Placenta Business Overview
13.6 Brooklyn Placenta Services
13.6.1 Brooklyn Placenta Services Company Details
13.6.2 Company Product Offered
13.6.3 Brooklyn Placenta Services Placenta Sales, Revenue and Gross Margin (2019-2024)
13.6.4 Brooklyn Placenta Services Placenta Business Overview